Knowledge mapping of biological disease-modifying anti-rheumatic drugs for axial spondyloarthritis: a bibliometric study Qian HeJia-qi ChenQing-wen Tao REVIEW ARTICLE 27 February 2023 Pages: 1999 - 2011
The Hong Kong Society of Rheumatology consensus recommendations for the management of gout Ronald ML YipTommy T Cheungfor the Hong Kong Society of Rheumatology REVIEW ARTICLE Open access 04 April 2023 Pages: 2013 - 2027
Systemic lupus erythematosus and thyroid disease: a Mendelian randomization study Lincheng DuanYue ShiYue Feng ORIGINAL ARTICLE 17 April 2023 Pages: 2029 - 2035
Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry Anthony SebbaClifton O. BinghamErnest Choy ORIGINAL ARTICLE Open access 15 April 2023 Pages: 2037 - 2051
Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis Maria A. Lopez-OlivoKaleb MichaudMaria E. Suarez-Almazor ORIGINAL ARTICLE 24 April 2023 Pages: 2053 - 2068
Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients Yasumori SobueMochihito SuzukiShiro Imagama ORIGINAL ARTICLE 22 May 2023 Pages: 2069 - 2077
Tuberculosis remains a leading contributor to morbidity due to serious infections in Indian patients of SLE Rudrarpan ChatterjeeSarit Sekhar PattanaikAmita Aggarwal ORIGINAL ARTICLE 11 April 2023 Pages: 2079 - 2090
Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus Maria Emilia Romero NoboaHugo Lopez-ArevaloAugustine M. Manadan ORIGINAL ARTICLE 20 April 2023 Pages: 2091 - 2095
Serum salusin-β levels in patients with systemic lupus erythematosus Mehrzad HajialiloRazieh JorjaniAlireza Khabbazi ORIGINAL ARTICLE 29 April 2023 Pages: 2097 - 2103
Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus Epitácio D. S. NetoTaurino S. R. NetoLeandro C. Zacharias ORIGINAL ARTICLE 01 May 2023 Pages: 2105 - 2114
Predictors of treatment outcomes in lupus nephritis with severe acute kidney injury and requirement of dialytic support Sofia E. Márquez-MacedoAbril A. Perez-AriasJuan M. Mejía-Vilet ORIGINAL ARTICLE 16 May 2023 Pages: 2115 - 2123
Assessment of calcinosis in Portuguese patients with systemic sclerosis — a multicenter study Beatriz SamõesDiogo Guimarães da FonsecaJoana Abelha-Aleixo ORIGINAL ARTICLE 08 May 2023 Pages: 2125 - 2134
Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties Devrim Can SaracDeniz BayraktarServet Akar ORIGINAL ARTICLE 13 May 2023 Pages: 2135 - 2143
Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis Panpan ZhangMengdi LiYusheng Zhang Original Article 09 May 2023 Pages: 2145 - 2154
Mycophenolate mofetil as induction and maintenance immunosuppressive therapy in adult primary central nervous system vasculitis: A prospective observational study Shyamashis DasRudra Prosad GoswamiAshis Datta BRIEF REPORT 18 April 2023 Pages: 2155 - 2162
Incidental findings on FDG-PET/CT in large vessel vasculitis Varinder HansJonathan AbeleElaine Yacyshyn BRIEF REPORT 22 April 2023 Pages: 2163 - 2171
What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey Gillian R. CurrieCatherina G.M. Groothuis-OudshoornDeborah A Marshall Original Article 19 May 2023 Pages: 2173 - 2180
Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study Luis M. Amezcua-GuerraFernanda Espinosa-BautistaCarlos Pineda BRIEF REPORT 18 April 2023 Pages: 2181 - 2186
Association of interleukin 33 gene polymorphisms with susceptibility and regulation of inflammatory mediators in Systemic lupus erythematosus patients Zahra Bagheri-HosseinabadiMohammad Reza MirzaeiMitra Abbasifard ORIGINAL ARTICLE 17 April 2023 Pages: 2187 - 2197
Sociocultural and moral narratives influencing the decision to vaccinate among rheumatic disease patients: a qualitative study Amaranta Manrique de LaraTirsa Colmenares-RoaIngris Peláez-Ballestas ORIGINAL ARTICLE 02 May 2023 Pages: 2199 - 2207
Network pharmacological analysis to reveal the mechanism governing the effect of Qin Xi Tong on osteoarthritis and rheumatoid arthritis Yanyan LvJie ZhangXiaoqiang Huang Original Article 10 May 2023 Pages: 2209 - 2222
Cardiac wall rupture in systemic lupus erythematosus: a case report and review of the literature Pawut GumraiKittiya Na-NanWorawit Louthrenoo CASE BASED REVIEW 04 May 2023 Pages: 2223 - 2229
Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature Jessica ChumskyPhilip J. KahnKirsty Hillier CASE BASED REVIEW 08 May 2023 Pages: 2231 - 2236
Refractory alopecia in lupus treated with tofacitinib — a case-based review Rajdeep SarkarPrakashini MVSakir Ahmed CASE BASED REVIEW 15 May 2023 Pages: 2237 - 2241
Palpebral perforation secondary to a dacryoadenitis: a rare complication of granulomatosis with polyangiitis Rémi PhilipAchille AoubaNicolas Martin-Silva CLINICAL IMAGE 22 April 2023 Pages: 2245 - 2246
Pulmonary hypertension secondary to Takayasu arteritis and atrial septal defect Aldo Cabello-GanemJavier Serrano-RomanNilda Espinola-Zavaleta CLINICAL IMAGE 24 April 2023 Pages: 2247 - 2248
Anti-synthetase syndrome and the risk of progressive pulmonary fibrosis: weighting of concomitant anti-Ro/SSA antibodies David Bernal-BelloJorge Rodríguez-RodríguezBegoña Frutos-Pérez Letter to the Editor 15 May 2023 Pages: 2249 - 2250